Center Laboratories (TWO:4123) — Stock Price
Center Laboratories (TWO:4123) is currently trading at NT$39.40 TWD, up 0.77% today. Over the past 52 weeks, shares have ranged between NT$33.60 and NT$49.35. This page tracks Center Laboratories's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Center Laboratories market cap and net worth.
Center Laboratories (4123) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Center Laboratories's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Center Laboratories Income Statement — Revenue, Profit & Earnings by Year
Center Laboratories's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | NT$1.62 Billion | NT$1.39 Billion | NT$767.72 Million | NT$500.11 Million | NT$717.04 Million |
| Cost of Revenue | NT$868.92 Million | NT$775.91 Million | NT$361.45 Million | NT$240.45 Million | NT$366.75 Million |
| Gross Profit | NT$748.95 Million | NT$618.09 Million | NT$406.27 Million | NT$259.66 Million | NT$350.30 Million |
| Research & Development | NT$71.96 Million | NT$82.76 Million | NT$47.02 Million | NT$75.40 Million | NT$128.87 Million |
| SG&A | NT$442.67 Million | NT$247.86 Million | NT$157.03 Million | NT$327.71 Million | NT$523.33 Million |
| Total Operating Expenses | NT$1.38 Billion | NT$697.36 Million | NT$121.83 Million | NT$513.81 Million | NT$823.10 Million |
| Operating Income | NT$234.32 Million | NT$-79.27 Million | NT$131.94 Million | NT$1.04 Billion | NT$291.97 Million |
| EBITDA | — | NT$-175.17 Million | NT$164.96 Million | NT$1.08 Billion | NT$349.11 Million |
| EBIT | — | NT$-317.77 Million | NT$136.97 Million | NT$1.05 Billion | NT$297.03 Million |
| Interest Expense | NT$227.53 Million | NT$200.18 Million | NT$82.69 Million | NT$102.75 Million | NT$83.34 Million |
| Income Before Tax | NT$-1.17 Billion | NT$-1.11 Billion | NT$-588.91 Million | NT$2.60 Billion | NT$6.00 Billion |
| Income Tax Expense | — | NT$-66.26 Million | NT$-13.29 Million | NT$438.69 Million | NT$1.11 Billion |
| Net Income | NT$-1.10 Billion | NT$-1.05 Billion | NT$-575.62 Million | NT$1.82 Billion | NT$3.79 Billion |
Center Laboratories Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Center Laboratories's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | NT$25.54 Billion | NT$27.00 Billion | NT$25.19 Billion | NT$30.44 Billion | NT$27.87 Billion |
| Total Current Assets | NT$3.78 Billion | NT$5.12 Billion | NT$2.85 Billion | NT$10.89 Billion | NT$1.43 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$1.79 Billion | NT$2.85 Billion | NT$1.77 Billion | NT$4.83 Billion | NT$244.89 Million |
| Net Receivables | NT$178.58 Million | NT$269.17 Million | NT$188.87 Million | NT$5.68 Billion | NT$149.19 Million |
| Inventory | NT$309.70 Million | NT$269.23 Million | NT$89.31 Million | NT$100.64 Million | NT$108.26 Million |
| Property, Plant & Equipment | — | — | — | NT$743.04 Million | NT$763.73 Million |
| Goodwill | — | NT$398.36 Million | NT$1.34 Million | — | NT$1.34 Million |
| Total Liabilities | NT$7.48 Billion | NT$6.79 Billion | NT$5.94 Billion | NT$9.35 Billion | NT$7.23 Billion |
| Total Current Liabilities | NT$4.62 Billion | NT$1.85 Billion | NT$3.92 Billion | NT$2.68 Billion | NT$2.76 Billion |
| Long-term Debt | NT$2.65 Billion | NT$4.41 Billion | NT$1.29 Billion | NT$3.68 Billion | NT$1.78 Billion |
| Net Debt | NT$5.07 Billion | NT$3.92 Billion | NT$2.68 Billion | NT$5.00 Billion | NT$2.84 Billion |
| Total Stockholder Equity | NT$18.05 Billion | NT$19.76 Billion | NT$19.25 Billion | NT$18.94 Billion | NT$17.98 Billion |
| Retained Earnings | NT$-1.37 Billion | NT$-1.00 Billion | NT$522.31 Million | NT$2.88 Billion | NT$3.77 Billion |
Center Laboratories Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Center Laboratories generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$415.71 Million | NT$-963.44 Million | NT$-189.88 Million | NT$-358.14 Million | NT$-269.56 Million |
| Capital Expenditures | NT$180.83 Million | NT$157.16 Million | NT$7.55 Million | NT$6.65 Million | NT$72.83 Million |
| Free Cash Flow | NT$234.89 Million | NT$-1.12 Billion | NT$-197.43 Million | NT$-364.79 Million | NT$-342.40 Million |
| Investing Cash Flow | — | — | — | NT$-655.88 Million | NT$305.67 Million |
| Financing Cash Flow | — | NT$2.00 Billion | NT$-4.46 Billion | NT$358.10 Million | NT$224.94 Million |
| Dividends Paid | NT$-1.03 Billion | NT$589.92 Million | NT$1.75 Billion | NT$1.05 Billion | NT$623.67 Million |
| Stock-Based Compensation | NT$803.00K | NT$0.00 | NT$0.00 | NT$3.89 Million | NT$43.41 Million |
| Depreciation | NT$161.07 Million | NT$147.94 Million | NT$33.02 Million | NT$34.57 Million | NT$57.14 Million |
| Change in Cash | NT$-262.32 Million | NT$907.85 Million | NT$529.28 Million | NT$-655.92 Million | NT$257.27 Million |
Center Laboratories Earnings History — EPS Actual vs. Analyst Estimates
Track Center Laboratories's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 11, 2026 | — | — | — |
| Mar 09, 2026 | — | — | — |
| Nov 10, 2025 | — | — | — |
| Aug 11, 2025 | — | — | — |
| May 12, 2025 | — | — | — |
| Mar 10, 2025 | — | — | — |
| Nov 08, 2024 | — | — | — |
| May 12, 2023 | 1.60 | — | — |